Unrelated Donor Hematopoietic Stem Cell Transplantation for the Treatment of Non-Malignant Genetic Diseases: An Alemtuzumab Based Regimen Is Associated With Cure of Clinical Disease; Earlier Clearance of Alemtuzumab May Be Associated With Graft Rejection

American Journal of Hematology - United States

doi 10.1002/ajh.24141